Immune checkpoint inhibitor (ICI) has become one of the important methods in the treatment of advanced tumors, and has significant survival advantages. However, ICI is often associated with immune-related adverse events (irAE), among which intestinal adverse events (such as colitis) are more common. The main symptoms include diarrhea, abdominal pain and intestinal bleeding. Although intestinal irAE induced by ICI has similar intestinal immune response and medical history characteristics to inflammatory bowel disease, the course of the disease progresses rapidly, and usually involving antagonism of immune signaling pathway and dysactivation of T cells. ICI adverse events (AE) should be confirmed according to clinical manifestations and related examinations, and then treated according to the severity of symptoms. In recent years, a large number of studies based on high-resolution omics data and artificial intelligence technology, especially intestinal flora and in vitro intestinal organoid models, have provided new methods and tools for predicting and evaluating the efficacy of ICI, exploring the mechanism and treatment strategy of irAE.
| 科 Family | 属数 Number of genus | 种数 Number of species | 占总种数比例 Percentage of total species (%) | 属 Genus | 种数 Number of species | 占总种数比例 Percentage of total species (%) |
|---|---|---|---|---|---|---|
| 鹅膏菌科Amanitaceae | 2 | 11 | 5.26 | 鹅膏菌属 Amanita | 10 | 4.78 |
| 小菇科 Mycenaceae | 2 | 12 | 5.74 | 丝盖伞属 Inocybe | 5 | 2.39 |
| 多孔菌科 Polyporaceae | 8 | 14 | 6.70 | 蜡蘑属 Laccaria | 5 | 2.39 |
| 红菇科 Russulaceae | 3 | 23 | 11.00 | 小皮伞属 Marasmius | 6 | 2.87 |
| 小菇属 Mycena | 11 | 5.26 | ||||
| 光柄菇属 Pluteus | 5 | 2.39 | ||||
| 红菇属 Russula | 17 | 8.13 | ||||
| 栓菌属 Trametes | 5 | 2.39 |